» Articles » PMID: 1994609

Adenomas and Hyperplastic Polyps in Screening Studies

Overview
Journal World J Surg
Publisher Wiley
Specialty General Surgery
Date 1991 Jan 1
PMID 1994609
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

A survey is given of colorectal polyps detected in a prospective randomized screening study with the fecal occult blood test. It is demonstrated that colonoscopy in persons with positive Hemoccult-II tests results in detection of and removal of a higher number of adenomas than among controls. The strategy may, therefore, possibly be followed by a reduction of the incidence of colorectal cancer. Screen-detected adenomas were most often in males and were larger than among controls; they were most often in the sigmoid colon, whereas the rectum was the most frequent location for adenomas in controls. Eight percent of persons with screen-detected adenomas had some symptoms, which could be referred to adenomas, in contrast to 50% among controls. Hyperplastic polyps served as markers for adenomas in persons with positive Hemoccult-II as well as in controls with adenomas detected by colonoscopy; however, most persons with adenomas had no hyperplastic polyps. Endoscopic polypectomy did not result in any severe complications, but surgical removal in 2 of 22 patients proved fatal. The results presented are compared with those of other prospective randomized trials. The optimistic view--that the incidence of cancer may be reduced by polypectomy in persons with positive Hemoccult-II tests--stresses the importance of securing optimal colonoscopy service.

Citing Articles

Prophylactic submucosal saline-adrenaline injection in colonoscopic polypectomy: prospective randomized study.

Dobrowolski S, Dobosz M, Babicki A, Dymecki D, Hac S Surg Endosc. 2004; 18(6):990-3.

PMID: 15108107 DOI: 10.1007/s00464-003-9214-6.

References
1.
Klaaborg K, Madsen M, Sondergaard O, Kronborg O . Participation in mass screening for colorectal cancer with fecal occult blood test. Scand J Gastroenterol. 1986; 21(10):1180-4. DOI: 10.3109/00365528608996440. View

2.
Kronborg O, Fenger C, Olsen J, Bech K, Sondergaard O . Repeated screening for colorectal cancer with fecal occult blood test. A prospective randomized study at Funen, Denmark. Scand J Gastroenterol. 1989; 24(5):599-606. DOI: 10.3109/00365528909093096. View

3.
Fenger C, Bak M, Kronborg O, Svanholm H . Observer reproducibility in grading dysplasia in colorectal adenomas: comparison between two different grading systems. J Clin Pathol. 1990; 43(4):320-4. PMC: 502369. DOI: 10.1136/jcp.43.4.320. View

4.
Kronborg O, Fenger C . Prognostic evaluation of planned follow-up in patients with colorectal adenomas. An interim report. Int J Colorectal Dis. 1987; 2(4):203-7. DOI: 10.1007/BF01649506. View

5.
Kronborg O, Fenger C, Sondergaard O, Pedersen K, Olsen J . Initial mass screening for colorectal cancer with fecal occult blood test. A prospective randomized study at Funen in Denmark. Scand J Gastroenterol. 1987; 22(6):677-86. DOI: 10.3109/00365528709011142. View